News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
164 Results
Type
Article (32)
Press Release (132)
Section
Business (42)
Deals (8)
Drug Development (53)
FDA (5)
Job Trends (1)
News (87)
Policy (10)
Tag
Academia (1)
Alliances (6)
Approvals (5)
Best Places to Work (1)
Clinical research (49)
COVID-19 (6)
Data (1)
Diagnostics (1)
Earnings (26)
Events (33)
Executive appointments (1)
FDA (5)
Government (2)
Healthcare (1)
Infectious disease (6)
IPO (7)
Medical device (1)
Medtech (1)
Mergers & acquisitions (1)
NextGen: Class of 2025 (1)
People (12)
Phase I (11)
Phase II (36)
Phase III (18)
Preclinical (3)
Real estate (3)
Regulatory (10)
Research institute (2)
Startups (1)
United States (4)
Date
Last 7 days (1)
Last 30 days (1)
Last 365 days (27)
2025 (11)
2024 (24)
2023 (18)
2022 (31)
2021 (30)
2020 (16)
2019 (13)
2018 (12)
2017 (4)
2016 (2)
2014 (1)
Location
Asia (8)
Australia (1)
Europe (144)
Georgia (1)
Maryland (1)
Michigan (1)
North Carolina (1)
164 Results for "inflarx".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
InflaRx to Report First Quarter 2025 Results on May 7, 2025
April 30, 2025
·
2 min read
Press Releases
InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
March 20, 2025
·
27 min read
Press Releases
InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
March 10, 2025
·
9 min read
Press Releases
InflaRx to Showcase Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
February 28, 2025
·
7 min read
Press Releases
InflaRx Announces Participation in Guggenheim SMID Cap Biotech Conference
January 23, 2025
·
2 min read
Press Releases
InflaRx Announces Participation in January Events in San Francisco
January 7, 2025
·
2 min read
Press Releases
InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences
February 25, 2025
·
3 min read
Press Releases
InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
February 19, 2025
·
4 min read
Press Releases
InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants
February 13, 2025
·
4 min read
Business
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
InflaRx N.V. announced financial results for the three months ended March 31, 2024, and provided an operating update.
May 8, 2024
·
20 min read
1 of 17
Next
